LI

Lipocine

LPCN
NASDAQHealth Care

Recent Patents

lpcn
1 year ago

Filed a patent for "compositions and methods for treating cns disorders" on Mon, February 12, 2024

New US Patent
lpcn
1 year ago

Filed a patent for "testosterone dodecanoate compositions and methods" on Thu, January 30, 2025

New US Patent
lpcn
over 1 year ago

Filed a patent for "bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one esters" on Wed, November 22, 2023

New US Patent
lpcn
over 1 year ago

Filed a patent for "oral testosterone therapy" on Mon, April 22, 2024

New US Patent
lpcn
over 1 year ago

Filed a patent for "oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy" on Thu, July 25, 2024

New US Patent
lpcn
over 1 year ago

Filed a patent for "oral allopregnanolone compositions and methods of use" on Thu, August 1, 2024

New US Patent
lpcn
almost 2 years ago

Filed a patent for "fixed dose oral testosterone undecanoate compositions and use thereof" on Wed, September 21, 2022

New US Patent
lpcn
almost 2 years ago

Filed a patent for "oral testosterone therapy" on Tue, May 2, 2023

New US Patent
lpcn
almost 2 years ago

Filed a patent for "method and composition for treating epilepsy" on Thu, December 7, 2023

New US Patent
lpcn
almost 2 years ago

Filed a patent for "steroidal compositions" on Thu, January 11, 2024

New US Patent
lpcn
almost 2 years ago

Filed a patent for "oral (17-ß)-3-oxoandrost-4-en-17-yl tridecanoate therapy" on Thu, May 30, 2024

New US Patent
lpcn
almost 2 years ago

Filed a patent for "oral allopregnanolone compositions and methods of use" on Thu, May 30, 2024

New US Patent
lpcn
almost 2 years ago

Filed a patent for "oral allopregnanolone compositions and methods of use" on Mon, August 29, 2022

New US Patent
lpcn
almost 2 years ago

Filed a patent for "compositions and methods for treating cns disorders" on Thu, May 16, 2024

New US Patent
lpcn
2 years ago

Filed a patent for "3alpha-oh-5beta-pregnan-20-one compositions and methods for treating central nervous system disorders" on Thu, October 12, 2023

New US Patent
lpcn
2 years ago

Filed a patent for "compositions and methods for treating cns disorders" on Thu, November 10, 2022

New US Patent
lpcn
2 years ago

Filed a patent for "(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use" on Thu, October 20, 2022

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...